Cargando…
C-X-C Motif Chemokine Ligand 14 is a Unique Multifunctional Regulator of Tumor Progression
Cancer is a leading cause of death and disease worldwide, with a tremendous financial impact. Thus, the development of cost-effective novel approaches for suppressing tumor growth and progression is essential. In an attempt to identify the mechanisms responsible for tumor suppression, we screened fo...
Autores principales: | Yang, Xiao-Yan, Ozawa, Shigeyuki, Kato, Yasumasa, Maehata, Yojiro, Izukuri, Kazuhito, Ikoma, Takeharu, Kanamori, Keisuke, Akasaka, Tetsu, Suzuki, Kenji, Iwabuchi, Hiroshi, Kurata, Shun-Ichi, Katoh, Iyoko, Sakurai, Takashi, Kiyono, Tohru, Hata, Ryu-Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514660/ https://www.ncbi.nlm.nih.gov/pubmed/31014014 http://dx.doi.org/10.3390/ijms20081872 |
Ejemplares similares
-
Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice
por: Hata, Ryu-Ichiro, et al.
Publicado: (2015) -
C-terminal α Domain of p63 Binds to p300 to Coactivate β-Catenin
por: Katoh, Iyoko, et al.
Publicado: (2019) -
Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma
por: Kondo, T, et al.
Publicado: (2016) -
Acidic extracellular microenvironment and cancer
por: Kato, Yasumasa, et al.
Publicado: (2013) -
ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma
por: Katoh, Iyoko, et al.
Publicado: (2023)